ZA871663B - Cyclodextrin clathrates of carbacyclin analogs,and agents containing same - Google Patents
Cyclodextrin clathrates of carbacyclin analogs,and agents containing sameInfo
- Publication number
- ZA871663B ZA871663B ZA871663A ZA871663A ZA871663B ZA 871663 B ZA871663 B ZA 871663B ZA 871663 A ZA871663 A ZA 871663A ZA 871663 A ZA871663 A ZA 871663A ZA 871663 B ZA871663 B ZA 871663B
- Authority
- ZA
- South Africa
- Prior art keywords
- agents containing
- containing same
- cyclodextrin clathrates
- carbacyclin analogs
- carbacyclin
- Prior art date
Links
- XZFRIPGNUQRGPI-WLPVIMDJSA-N Carbacyclin Chemical class C1\C(=C\CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 XZFRIPGNUQRGPI-WLPVIMDJSA-N 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
- C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
- C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3608088A DE3608088C2 (de) | 1986-03-07 | 1986-03-07 | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA871663B true ZA871663B (en) | 1987-08-28 |
Family
ID=6296073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA871663A ZA871663B (en) | 1986-03-07 | 1987-03-06 | Cyclodextrin clathrates of carbacyclin analogs,and agents containing same |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4886788A (sv) |
| EP (1) | EP0259468B1 (sv) |
| JP (2) | JPH07107020B2 (sv) |
| AT (1) | AT397084B (sv) |
| AU (2) | AU6988687A (sv) |
| CA (1) | CA1309087C (sv) |
| CH (1) | CH672313A5 (sv) |
| CS (1) | CS270558B2 (sv) |
| DD (1) | DD258942A5 (sv) |
| DE (3) | DE3608088C2 (sv) |
| ES (1) | ES2004543A6 (sv) |
| FI (1) | FI92388C (sv) |
| GB (2) | GB2189783A (sv) |
| GR (1) | GR870363B (sv) |
| HU (1) | HU198906B (sv) |
| IE (1) | IE59760B1 (sv) |
| IL (1) | IL81802A (sv) |
| NO (1) | NO173440C (sv) |
| NZ (1) | NZ219508A (sv) |
| SU (1) | SU1632371A3 (sv) |
| WO (1) | WO1987005294A1 (sv) |
| ZA (1) | ZA871663B (sv) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663316A (en) * | 1985-06-28 | 1987-05-05 | Warner-Lambert Company | Antibiotic clathrates and pharmaceutical compositions thereof |
| DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
| DE3740838A1 (de) * | 1987-11-27 | 1989-06-08 | Schering Ag | Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel |
| ATE122563T1 (de) * | 1989-07-27 | 1995-06-15 | Ueno Seiyaku Oyo Kenkyujo Kk | Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions. |
| DE3933523A1 (de) * | 1989-10-05 | 1991-04-11 | Schering Ag | Antimetastatisch wirkende mittel |
| DE4010355A1 (de) * | 1990-03-28 | 1991-10-02 | Schering Ag | Bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
| DE4104606C1 (sv) * | 1991-02-12 | 1992-10-15 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
| US5221735A (en) * | 1991-02-25 | 1993-06-22 | Hoffmann-La Roche Inc. | Cyclodextrin-polyene inclusion complexes |
| DE4135193C1 (sv) * | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
| US6103403A (en) * | 1997-05-15 | 2000-08-15 | University Of Kentucky Research Foundation Intellectual Property Development | Clathrate structure for electronic and electro-optic applications |
| DE19808634A1 (de) * | 1998-02-24 | 1999-08-26 | Schering Ag | Mantel für eine pharmazeutische Zusammensetzung |
| DE19828881A1 (de) | 1998-06-22 | 1999-12-23 | Schering Ag | Oxidationsinhibitor bei Prostan-Derivaten |
| DE10225551A1 (de) * | 2002-06-06 | 2003-12-24 | Schering Ag | Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind |
| MY144968A (en) * | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| MY145694A (en) * | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
| US7737145B2 (en) | 2005-12-29 | 2010-06-15 | Estrellita Pharmaceuticals, Llc | Diamine derivatives as inhibitors of leukotriene A4 hydrolase |
| US20100016427A1 (en) * | 2006-08-11 | 2010-01-21 | Taishio Pharmaceutical Co., Ltd. | External preparation comprising prostaglandin derivative |
| ATE545416T1 (de) | 2006-10-12 | 2012-03-15 | Xenon Pharmaceuticals Inc | Verwendung von spiro-oxindol-verbindungen als therapeutika |
| AU2007307638A1 (en) * | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro (furo [3, 2-C] pyridine-3-3 ' -indol) -2' (1'H)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| CN106928247A (zh) * | 2008-10-17 | 2017-07-07 | 泽农医药公司 | 螺羟吲哚化合物及其作为治疗剂的用途 |
| WO2010045197A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| WO2011047173A2 (en) | 2009-10-14 | 2011-04-21 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
| EP2733145A1 (en) | 2009-10-14 | 2014-05-21 | Xenon Pharmaceuticals Inc. | Synthetic methods for spiro-oxindole compounds |
| RU2596488C2 (ru) | 2010-02-26 | 2016-09-10 | Ксенон Фармасьютикалз Инк. | Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов |
| EP2838902B1 (en) | 2012-04-12 | 2018-12-05 | Xenon Pharmaceuticals Inc. | Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
| BR112015022226A2 (pt) | 2013-03-14 | 2017-07-18 | Celtaxsys Inc | inibidores de leucotrieno a4 hidrolase |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| WO2017218920A1 (en) | 2016-06-16 | 2017-12-21 | Teva Pharmaceuticals International Gmbh | Asymmetric synthesis of funapide |
| WO2018107158A1 (en) | 2016-12-09 | 2018-06-14 | Celtaxsys, Inc. | Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase |
| EP3551628A1 (en) | 2016-12-09 | 2019-10-16 | Celtaxsys Inc. | Inhibitors of leukotriene a4 hydrolase |
| US10202334B2 (en) | 2016-12-09 | 2019-02-12 | Celtaxsys, Inc. | Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase |
| HU231212B1 (hu) * | 2018-04-16 | 2021-11-29 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Eljárás iloprost előállítására |
| RU2741848C1 (ru) * | 2019-03-16 | 2021-01-29 | Иванова Мария Ивановна | Способ получения клатратных комплексов летучих веществ |
| JPWO2023037934A1 (sv) * | 2021-09-13 | 2023-03-16 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503362B1 (sv) * | 1970-06-10 | 1975-02-04 | ||
| AU476695B2 (en) * | 1974-01-15 | 1975-07-17 | Ono Pharmaceutical Co. Ltd | Clathrate prostaglandins and compositions containing same |
| HU179141B (sv) * | 1977-09-23 | 1982-08-28 | ||
| IT1113341B (it) * | 1978-03-31 | 1986-01-20 | Ono Pharmaceutical Co | Analoghi della 6,9-metano-pgi2 |
| DE2845770A1 (de) * | 1978-10-19 | 1980-04-30 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| DE2950027A1 (de) * | 1979-12-10 | 1981-06-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin | 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel |
| JPS56150039A (en) * | 1980-04-22 | 1981-11-20 | Sankyo Co Ltd | Clathrate compound of prostacycline derivative |
| DE3126924A1 (de) * | 1981-07-03 | 1983-01-20 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel |
| JPS5818357A (ja) * | 1981-07-28 | 1983-02-02 | Ono Pharmaceut Co Ltd | ６，９−メタノ−ｐｇｉ↓２及び６，９−メタノ−ｐｇｉ↓２類似化合物の安定化組成物及びその製造方法 |
| JPS58116423A (ja) * | 1981-12-28 | 1983-07-11 | Sumitomo Chem Co Ltd | メタノプロスタサイクリン製剤組成物 |
| JPS58192821A (ja) * | 1982-04-30 | 1983-11-10 | Dainippon Pharmaceut Co Ltd | 脳神経細胞の酸素欠乏性疾患の治療剤 |
| US4517202A (en) * | 1982-05-28 | 1985-05-14 | May & Baker Limited | Prostaglandin analogues |
| JPS59141536A (ja) * | 1983-02-01 | 1984-08-14 | Sumitomo Chem Co Ltd | 新規ビシクロオクタン誘導体 |
| DE3306123A1 (de) * | 1983-02-18 | 1984-09-06 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| FR2547818B1 (fr) * | 1983-05-24 | 1986-09-05 | May & Baker Ltd | Nouveaux analogues de prostaglandines, leur preparation, les compositions pharmaceutiques qui les contiennent et les intermediaires-cles pour les preparer |
| DE3405181A1 (de) * | 1984-02-10 | 1985-08-22 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JPS6144819A (ja) * | 1984-08-09 | 1986-03-04 | Sagami Chem Res Center | プロスタグランジンｉ２類縁化合物を含有する循環改善作用を有する薬剤 |
| EP0171992B1 (en) * | 1984-08-09 | 1990-06-06 | Mitsubishi Kasei Corporation | Pharmaceuticals containing prostaglandin i2 |
| JPS6216A (ja) * | 1985-03-19 | 1987-01-06 | Sankyo Co Ltd | カルバサイクリン類及びこれを有効成分とする抗潰瘍剤 |
| DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
-
1986
- 1986-03-07 DE DE3608088A patent/DE3608088C2/de not_active Expired - Lifetime
-
1987
- 1987-03-03 DD DD87300413A patent/DD258942A5/de not_active IP Right Cessation
- 1987-03-03 GB GB08704982A patent/GB2189783A/en not_active Withdrawn
- 1987-03-04 GR GR870363A patent/GR870363B/el unknown
- 1987-03-05 NZ NZ219508A patent/NZ219508A/xx unknown
- 1987-03-05 IL IL81802A patent/IL81802A/xx not_active IP Right Cessation
- 1987-03-06 CA CA000531395A patent/CA1309087C/en not_active Expired - Lifetime
- 1987-03-06 CS CS871511A patent/CS270558B2/cs not_active IP Right Cessation
- 1987-03-06 ZA ZA871663A patent/ZA871663B/xx unknown
- 1987-03-07 ES ES8700629A patent/ES2004543A6/es not_active Expired
- 1987-03-09 WO PCT/DE1987/000106 patent/WO1987005294A1/de active IP Right Grant
- 1987-03-09 HU HU871916A patent/HU198906B/hu unknown
- 1987-03-09 AT AT0900787A patent/AT397084B/de active
- 1987-03-09 IE IE58687A patent/IE59760B1/en not_active IP Right Cessation
- 1987-03-09 DE DE87DE8700106T patent/DE3790121D2/de not_active Expired
- 1987-03-09 GB GB8725695A patent/GB2199031B/en not_active Expired - Lifetime
- 1987-03-09 AU AU69886/87A patent/AU6988687A/en not_active Abandoned
- 1987-03-09 DE DE8787902041T patent/DE3770085D1/de not_active Expired - Lifetime
- 1987-03-09 EP EP87902041A patent/EP0259468B1/de not_active Expired - Lifetime
- 1987-03-09 US US07/023,506 patent/US4886788A/en not_active Expired - Lifetime
- 1987-03-09 JP JP62501825A patent/JPH07107020B2/ja not_active Expired - Lifetime
- 1987-03-09 CH CH3687/87A patent/CH672313A5/de not_active IP Right Cessation
- 1987-03-09 AU AU71609/87A patent/AU609390B2/en not_active Expired
- 1987-10-07 FI FI874406A patent/FI92388C/sv not_active IP Right Cessation
- 1987-11-05 SU SU874203626A patent/SU1632371A3/ru active
- 1987-11-06 NO NO874632A patent/NO173440C/no unknown
-
1995
- 1995-04-24 JP JP7098975A patent/JP2634787B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA871663B (en) | Cyclodextrin clathrates of carbacyclin analogs,and agents containing same | |
| HUT47015A (en) | Smoking articless containing effect modifying agent | |
| AU566405B2 (en) | Peroxide containing mouthwash | |
| AU592236B2 (en) | Amplitude-adapted vector quantizer | |
| GB2199037B (en) | Separation of cyclodextrins | |
| GB8708974D0 (en) | Modified cyclodextrins | |
| GB8711581D0 (en) | Thickening agent | |
| AU6980987A (en) | Agglomerated bits containing asparmate | |
| HK6989A (en) | Carbacyclin analogues | |
| GB8432345D0 (en) | Cyclodextrins | |
| AU5068985A (en) | Dentifrice containing alginate calcium chelating agent | |
| JPS6490165A (en) | Cyclodextrin complex of bis-biguanidehexane compound | |
| AR243592A1 (es) | Composicion lubricante conteniendo azufre activo. | |
| AU2741884A (en) | Deodorising cosmetic agent | |
| GB2193963B (en) | Branched cyclodextrins | |
| NZ221328A (en) | A synergistic combination of t-pa and a prostaglandin, being pge, or a compound of formula i | |
| JPS6470447A (en) | Manufacture of 2,2'-oxybis(n,n-dimethylethaneamine) | |
| AU7920287A (en) | Desulphurisation | |
| ZA851337B (en) | Interphenylene carbacyclin derivatives | |
| AU1517788A (en) | Analogs of (1,7-DI-Alanine, des-19-leucine) | |
| AU3196184A (en) | Clathrates of n,n-dimethyl-2-chloro-5-(3-methyl-2- (phenylimino)-4-thiazolin-4-yl)phenylsulfonamide | |
| GB2192395B (en) | Carbacyclin derivatives | |
| GB8325709D0 (en) | Desulfurizing agent | |
| DE3276758D1 (en) | Use of (co)polytetramethylene-adipamide articles | |
| GB2121802B (en) | Benzo-fused carbacyclin analogues |